GlassScriptPhysician profile
Hasham Mohammed Alvi
NPI 1760793889
$148,659.50
in general payments reported to CMS, 2019-2025
21 companies · $7,346 in 2025
The $7,346 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,320 · 2020: $8,412 · 2021: $12K · 2022: $36K · 2023: $66K · 2024: $11K · 2025: $7,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $46K · Consulting Fee: $25K · Travel and Lodging: $8,237 · Food and Beverage: $4,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,169.67 |
| Consulting Fee | $24,898.46 |
| Travel and Lodging | $8,236.76 |
| Food and Beverage | $4,689.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $63,603.87 | 2019-2023 | |
| Microport Orthopedics INC | $63,578.72 | 2021-2025 | Mpo Medial Pivot Knee, Mpo Hip System |
| Medical Device Business Services, INC. | $7,371.82 | 2023-2025 | Attune, Kincise, Actis |
| Microport Navibot International LLC | $7,076.09 | 2022 | |
| Depuy Synthes Products, INC. | $2,306.05 | 2022 | |
| Depuy Synthes Sales INC. | $1,696.57 | 2019-2025 | Reclaim, Actis, Attune |
| Stryker Corporation | $1,033.56 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $542.48 | 2020-2022 | |
| Omnilife Science, INC | $422.26 | 2024-2025 | Various Products |
| Oak Med, INC. | $390.27 | 2024-2025 | |
| Medtronic, INC. | $209.28 | 2022-2025 | Aquamantys(Tm), Plasmablade(Tm) |
| Vertex Pharmaceuticals Incorporated | $78.78 | 2024-2025 | |
| Ethicon US, LLC | $71.80 | 2020-2023 | Dermabond |
| Horizon Therapeutics Plc | $63.79 | 2019 | |
| Heron Therapeutics, INC. | $59.67 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $48.33 | 2019 | |
| Trice Medical, INC. | $34.17 | 2019 | |
| Merck Sharp & Dohme LLC | $20.00 | 2024 | Bridion |
| Davol INC. | $19.92 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.17 | 2023 | Zilretta, Exparel, Iovera |
| E.R. Squibb & Sons, L.L.C. | $13.90 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasham Alvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.